A Novel Standardized <i>Cannabis sativa</i> L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
Cannabis and cannabinoids offer significant therapeutic benefits for a wide scope of pathological conditions. Among them, the clinical issues rooted in inflammation stand out, nonetheless, the underlying mechanisms are not yet plainly understood. Circumstantial evidence points to polymorphonuclear l...
Main Authors: | Alex Mabou Tagne, Franca Marino, Massimiliano Legnaro, Alessandra Luini, Barbara Pacchetti, Marco Cosentino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/8/1833 |
Similar Items
-
Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L
by: Laura Daniela Martinenghi, et al.
Published: (2020-06-01) -
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug Canabidiol, um componente da Cannabis sativa, como um ansiolítico
by: Alexandre Rafael de Mello Schier, et al.
Published: (2012-06-01) -
Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
by: Ana Pilar Pérez-Acevedo, et al.
Published: (2020-12-01) -
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
by: Zackary Montoya, et al.
Published: (2020-09-01) -
Limited effect of environmental stress on cannabinoid profiles in high‐cannabidiol hemp (Cannabis sativa L.)
by: Jacob A. Toth, et al.
Published: (2021-10-01)